| Ytd | -46.64% | |
| 1y | -63.84% |
| Open | 0.32 | Prev Close | 0.34 | Low | 0.32 | High | 0.34 | Mkt Cap | 21.43M |
| Vol | 111.59K | Avg Vol | 155.32K | EPS | -0.29 | P/E | N/A | Forward P/E | -5.99 |
| Beta | 0.56 | Short Ratio | 9.57 | Inst. Own | 33.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 0.38 | 200-d Avg | 0.57 | 1yr Est | 5.00 |
Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 38.0% to $3.45 during Monday's after-market se
Gainers Werewolf Therapeutics (NASDAQ:HOWL) stock moved upwards by 77.1% to $0.76 during Thursday&#
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday'
Cytosorbents Corporation (CTSO) Q2 2026 Earnings Call Transcript
Highlighting Four Independent Drivers of Shareholder Value PRINCETON, N.J., Aug. 6, 2026 /PRNewswire
PRINCETON, N.J., July 20, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in
PRINCETON, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader
Cytosorbents Corporation (CTSO) Q1 2026 Earnings Call Transcript
CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.05) per share which beat the analyst con
PRINCETON, N.J., May 13, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in t
PRINCETON, N.J., April 30, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in
Cytosorbents Corporation (CTSO) Q4 2025 Earnings Call Transcript
CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.07) per share which missed the analyst c
2025 revenue of $37.1 million, up 4% year-over-year, and 71% Full-year gross margins Enhanced Balanc
PRINCETON, N.J., March 19, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in
PRINCETON, N.J., March 5, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in
Fourth quarter and Full-Year 2025 revenue are expected to be approximately $9.2 million and $37.0 mi
Cytosorbents Corporation (CTSO) Discusses Progress in Blood-Purification Programs and DrugSorb-ATR's
PRINCETON, N.J. , Dec. 10, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in
PRINCETON, N.J. , Nov. 17, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader i
Cytosorbents Corporation ( CTSO ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Partic
Third quarter 2025 revenue of $9.5 million, up 10% year-over-year Amended credit agreement with Aven
PRINCETON, N.J. , Nov. 11, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in
PRINCETON, N.J. , Oct. 30, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in
PRINCETON, N.J. , Oct. 28, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for it
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100
Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s sessio
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is estimated to report earnings for it
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for
On Tuesday, 298 companies achieved new lows for the year.
Gainers
Gainers
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin